A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Clinical trial NCT03332797 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03332797
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-24
- Primary completion
- 2027-07-31
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.